Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Juan Manuel Carreño, Hala Alshammary, Johnstone Tcheou, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 682-688
Open Access | Times Cited: 476
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 10, pp. 951-963
Open Access | Times Cited: 117
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
The Lancet (2022) Vol. 399, Iss. 10328, pp. 905-907
Open Access | Times Cited: 82
The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2
Jeffrey P. Townsend, Hayley B. Hassler, Pratha Sah, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 71
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Juan Manuel Carreño, Hala Alshammary, Johnstone Tcheou, et al.
Nature (2021)
Open Access | Times Cited: 57
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
Alessio Mazzoni, Anna Vanni, Michele Spinicci, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
Stepan Nersisyan, Anton Zhiyanov, Maria V. Zakharova, et al.
PeerJ (2022) Vol. 10, pp. e13354-e13354
Open Access | Times Cited: 26
‘Killer’ immune cells still recognize Omicron variant
Heidi Ledford
Nature (2022) Vol. 601, Iss. 7893, pp. 307-307
Open Access | Times Cited: 24
Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities
Mohammad Shah Alam
Heliyon (2023) Vol. 9, Iss. 2, pp. e13285-e13285
Open Access | Times Cited: 16
Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly
Isabella A. T. M. Ferreira, Colin Y. C. Lee, William S. Foster, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112991-112991
Open Access | Times Cited: 16
A tabulated summary of the evidence on humoral and cellular responses to the SARS-CoV-2 Omicron VOC, as well as vaccine efficacy against this variant.
S.O Minka, F.-H. Minka
Immunology Letters (2022) Vol. 243, pp. 38-43
Open Access | Times Cited: 22
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
Niels J. M. Verstegen, Ruth R Hagen, Jet van den Dijssel, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 20
Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants
Matthew Chang, Hanzhong Ke, Christian D. Coherd, et al.
EBioMedicine (2022) Vol. 80, pp. 104025-104025
Open Access | Times Cited: 17
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates
Daniel Y. Zhu, Matthew J. Gorman, Dansu Yuan, et al.
PLoS Biology (2022) Vol. 20, Iss. 5, pp. e3001609-e3001609
Open Access | Times Cited: 16
T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern
Hagai Cohen, Shahar Rotem, Uri Elia, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 347-347
Open Access | Times Cited: 15
Impact in the humoral and cellular immune response to SARS-CoV-2 variants after primary vaccination with AZD1222/COVISHIELD protocol in healthy adults
Artur Capão, Mia Ferreira de Araújo, Luis Fernando López Tort, et al.
Vaccine (2025) Vol. 50, pp. 126785-126785
Closed Access
Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3
Srividhya Swaminathan, Katie E. Lineburg, Archana Panikkar, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
Céline Imhof, A. Lianne Messchendorp, Marieke van der Heiden, et al.
Transplantation Direct (2022) Vol. 8, Iss. 11, pp. e1387-e1387
Open Access | Times Cited: 12
T cell response following anti COVID-19 BNT162b2 vaccination is maintained against the SARS-CoV-2 Omicron B.1.1.529 variant of concern
Hagai Cohen, Shahar Rotem, Uri Elia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells
Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Immunogenicity and reactogenicity of SARS-CoV-2 mRNA and inactivated vaccines in healthy adolescents
YL Lau, Jaime S. Rosa Duque, Xiwei Wang, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 4
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
Arne Søraas, Gunnveig Grødeland, Beathe Kiland Granerud, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Comparison of two T cell assays to evaluate T cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers
Eloise Phillips, Sandra Adele, Tom Malone, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
Stepan Nersisyan, Anton Zhiyanov, Maria V. Zakharova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
SARS-CoV-2 Omicron Variant AI-based Primers
Carmina Angelica Perez-Romero, Alberto Tonda, Lucero Mendoza‐Maldonado, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1 - Next Page

Scroll to top